GR3002659T3 - Pharmaceutical composition for treating inflammation in the eye - Google Patents

Pharmaceutical composition for treating inflammation in the eye

Info

Publication number
GR3002659T3
GR3002659T3 GR91400904T GR910400904T GR3002659T3 GR 3002659 T3 GR3002659 T3 GR 3002659T3 GR 91400904 T GR91400904 T GR 91400904T GR 910400904 T GR910400904 T GR 910400904T GR 3002659 T3 GR3002659 T3 GR 3002659T3
Authority
GR
Greece
Prior art keywords
eye
pharmaceutical composition
treating inflammation
inflammation
treating
Prior art date
Application number
GR91400904T
Other languages
English (en)
Inventor
Johann Dr Doulakas
Original Assignee
Dispersa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6298657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3002659(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dispersa Ag filed Critical Dispersa Ag
Publication of GR3002659T3 publication Critical patent/GR3002659T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR91400904T 1986-04-14 1991-09-06 Pharmaceutical composition for treating inflammation in the eye GR3002659T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3612537A DE3612537C1 (de) 1986-04-14 1986-04-14 Arzneimittel zur Behandlung von Entzuendungen im Auge

Publications (1)

Publication Number Publication Date
GR3002659T3 true GR3002659T3 (en) 1993-01-25

Family

ID=6298657

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91400904T GR3002659T3 (en) 1986-04-14 1991-09-06 Pharmaceutical composition for treating inflammation in the eye

Country Status (12)

Country Link
US (1) US4829088A (el)
EP (1) EP0242328B1 (el)
JP (1) JP2515788B2 (el)
CA (1) CA1286225C (el)
DE (1) DE3612537C1 (el)
DK (1) DK164639C (el)
EG (1) EG18268A (el)
ES (1) ES2038691T4 (el)
GR (1) GR3002659T3 (el)
NO (1) NO174916C (el)
PT (1) PT84669B (el)
ZA (1) ZA872624B (el)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (el) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
ATE103182T1 (de) * 1989-09-21 1994-04-15 Ciba Vision Ag Antimikrobielle zusammensetzungen.
US6117907A (en) * 1993-04-14 2000-09-12 Sher; Neal A. Topical treatment of ocular pain after corneal surgery
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US6309630B1 (en) 1994-05-24 2001-10-30 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic suspensions
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
EP0807434B1 (en) * 1995-01-20 2002-04-10 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eyedrops
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
US5620970A (en) * 1995-06-05 1997-04-15 Alcon Laboratories, Inc. Topical ophthalmic carbonic anhydrase inhibitor formulations
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
WO1997024142A1 (fr) * 1995-12-27 1997-07-10 Showa Yakuhin Kako Co., Ltd. Composition aqueuse contenant de l'acide cromoglycique
US5814655A (en) * 1996-11-14 1998-09-29 Insite Vision Incorporated Non-steroidal ophthalmic mixtures
DE69713388T2 (de) * 1996-12-13 2002-10-31 Alcon Lab Inc Verwendung von niedermolekularen aminoalkoholen in ophthalmologischen präparaten
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6265444B1 (en) 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
JP2006111636A (ja) * 1997-12-26 2006-04-27 Astellas Pharma Inc 徐放性医薬組成物
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
US20050119299A1 (en) * 2002-03-08 2005-06-02 Sankyo Company, Limited Ophthalmic solutions containing tetrazole derivatives
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
JP4524538B2 (ja) * 2002-04-08 2010-08-18 ライオン株式会社 眼科用組成物
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
PL1808170T3 (pl) * 2004-11-05 2011-12-30 Senju Pharma Co Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową
LT2486942T (lt) 2004-11-24 2019-01-25 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną ir jų panaudojimo būdai
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
JP5108234B2 (ja) * 2005-02-07 2012-12-26 日本特殊陶業株式会社 マイクロヒータ及びセンサ
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
AU2007208054A1 (en) * 2006-01-25 2007-08-02 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
US20070212420A1 (en) * 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
US7829249B2 (en) * 2007-03-05 2010-11-09 Asml Netherlands B.V. Device manufacturing method, computer program and lithographic apparatus
TWI465236B (zh) * 2007-03-13 2014-12-21 參天製藥股份有限公司 含有吡諾克辛之懸浮型水性液劑
EP2160182A1 (en) * 2007-05-24 2010-03-10 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
US20130011469A1 (en) 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
JP5246182B2 (ja) * 2010-02-24 2013-07-24 ライオン株式会社 点眼剤、防腐剤及び防腐力向上剤
JP5299449B2 (ja) * 2011-02-23 2013-09-25 ライオン株式会社 外用剤組成物
JP2013082682A (ja) * 2011-09-29 2013-05-09 Senju Pharmaceut Co Ltd 亜塩素酸塩を含有する水性製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS58174309A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 消炎点眼剤
JPS58174310A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 抗炎症点眼剤

Also Published As

Publication number Publication date
CA1286225C (en) 1991-07-16
PT84669B (pt) 1989-11-30
EG18268A (en) 1993-02-28
NO871549L (no) 1987-10-15
NO174916C (no) 1994-08-03
EP0242328A2 (de) 1987-10-21
NO174916B (no) 1994-04-25
ES2038691T4 (es) 1995-09-01
US4829088A (en) 1989-05-09
NO871549D0 (no) 1987-04-13
DK176487D0 (da) 1987-04-07
DE3612537C1 (de) 1987-07-16
PT84669A (en) 1987-05-01
DK164639C (da) 1992-12-21
DK164639B (da) 1992-07-27
EP0242328A3 (en) 1988-04-06
ZA872624B (en) 1987-12-30
JPS62242617A (ja) 1987-10-23
DK176487A (da) 1987-10-15
ES2038691T3 (es) 1993-08-01
EP0242328B1 (de) 1991-07-24
JP2515788B2 (ja) 1996-07-10

Similar Documents

Publication Publication Date Title
EP0242328A3 (en) Pharmaceutical composition for treating inflammation in the eye
ZA895588B (en) Intravenou pharmaceutical composition and process for preparing the same
GB8613688D0 (en) Pharmaceutical composition
EP0304802A3 (en) Pharmaceutical composition and the use thereof
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
GB8825892D0 (en) Pharmaceutical composition
AU7793791A (en) Pharmaceutical composition for use in treating pain
GB2232891B (en) Pharmaceutical composition
ZA893422B (en) Pharmaceutical composition
GB8614189D0 (en) Pharmaceutical composition
HK1394A (en) Pharmaceutical composition for treating inflammation in the eye
SG13194G (en) Pharmaceutical composition for treating inflammation in the eye.
EP0478660A4 (en) Pharmaceutical compositions and methods for treating inflammation
RO105651B1 (ro) Compozitie medicamentoasa cu actiune antidiabetica
GR860348B (en) Pharmaceutical composition for the hair
IL80357A0 (en) Compositions with angiogenically active lipid-containing molecules and process for the preparation thereof
GB8811718D0 (en) Pharmaceutical compositions & treatment
GB8811717D0 (en) Pharmaceutical compositions & treatment
GB8809329D0 (en) Pharmaceutical compositions & treatment
GB8811716D0 (en) Pharmaceutical compositions & treatment
GB8908866D0 (en) Pharmaceutical compositions and treatment
GB8812530D0 (en) Ophthalmic composition
GB8921163D0 (en) Synergistically active compositions and process for preparing the same
IE862553L (en) Pharmaceutical compositions for treatment gastrointestinal¹disorders
ZA894202B (en) Glycosaminoglycan salts,processes for the preparation thereof and pharmaceutical composition containing them